Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Construction in Progress: 2023-2024

Historic Construction in Progress for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $1.3 million.

  • Zhengye Biotechnology Holding's Construction in Progress rose 26.30% to $1.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.3 million, marking a year-over-year increase of 26.30%. This contributed to the annual value of $1.3 million for FY2024, which is 23.97% up from last year.
  • Per Zhengye Biotechnology Holding's latest filing, its Construction in Progress stood at $1.3 million for FY2024, which was up 23.97% from $1.1 million recorded in FY2023.
  • Zhengye Biotechnology Holding's 5-year Construction in Progress high stood at $1.3 million for FY2024, and its period low was $1.1 million during FY2023.
  • Its 2-year average for Construction in Progress is $1.2 million, with a median of $1.2 million in 2024.
  • Data for Zhengye Biotechnology Holding's Construction in Progress shows a peak YoY climbed of 23.97% (in 2024) over the last 5 years.
  • Over the past 2 years, Zhengye Biotechnology Holding's Construction in Progress (Yearly) stood at $1.1 million in 2023, then climbed by 23.97% to $1.3 million in 2024.